StockStory favors Bloom Energy, urges caution on Kulicke & Soffa and Phibro Animal Health

StockStory on May 14, 2026, identified Bloom Energy (NYSE: BE) as a contrarian buying opportunity despite Wall Street’s bearish price target, while recommending caution on Kulicke & Soffa (NASDAQ: KLIC) and Phibro Animal Health (NASDAQ: PAHC). Bloom Energy traded at $264.45, above the consensus price target of $234.18, implying an 11.4% downside. The stock was valued at 115.9 times forward earnings. StockStory said Wall Street’s pessimism may be creating an opportunity in the fuel-cell systems maker. Kulicke & Soffa traded at $102.67, versus a $100 consensus target, implying 2.6% downside, and was valued at 24.1 times forward earnings. Phibro Animal Health traded at $41.08, below its $51.20 consensus target, implying 24.6% upside, with a 13.3 times forward price-to-earnings ratio. StockStory said skepticism toward both companies was warranted.